Phase I–II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: A regimen with a low subjective toxic burden
Open Access
- 1 August 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (9) , 865-870
- https://doi.org/10.1023/a:1008209429204
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer.Journal of Clinical Oncology, 1994
- Vinorelbine (Navelbine) as a salvage treatment for advanced breast cancerAnnals of Oncology, 1994
- Combination effect of navelbine (vinorelbine ditartrate) with cisplatin against murine P388 leukemia and human lung carcinoma xenografts in miceAnti-Cancer Drugs, 1993
- Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.Journal of Clinical Oncology, 1989
- Experimental antitumor activity of 5′-nor-anhydrovinblastine navelbineCancer Letters, 1984
- Cancer of the BreastNew England Journal of Medicine, 1980
- Combination chemotherapy for metastatic breast carcinoma.Prospective comparison of multiple drug therapy with L-phenylalanine mustardCancer, 1976
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958